We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+11.56%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$8.44B
AUM Growth
+$1.09B
(+15%)
Cap. Flow
+$577M
Cap. Flow
% of AUM
6.84%
Top 10 Holdings %
Top 10 Hldgs %
15.63%
Holding
838
New
218
Increased
181
Reduced
162
Closed
220
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$123M |
| 2 |
HES
Hess
HES
|
+$115M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$108M |
| 4 |
Cencora
COR
|
+$106M |
| 5 |
Microsoft
MSFT
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$108M |
| 2 |
Analog Devices
ADI
|
+$105M |
| 3 |
Keysight
KEYS
|
+$101M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$82.2M |
| 5 |
Booking.com
BKNG
|
+$58.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.55% |
| 2 | Technology | 28% |
| 3 | Industrials | 9.43% |
| 4 | Energy | 7.74% |
| 5 | Consumer Discretionary | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VSXY
426
Victoria's Secret
VSXY
$7.2B
| $2.08M | 0.02% |
+119,070
| New | +$3M |
|
|
OHAA
427
DELISTED
OPY Acquisition Corp. I Class A Common Stock
OHAA
| $2.05M | 0.02% |
200,000
| – | – |
|
428
Alignment Healthcare
ALHC
$2.87B
| $2.04M | 0.02% |
354,382
+271,580
| +328% | +$1.76M |
|
429
Capri Holdings
CPRI
$1.86B
| $2.03M | 0.02% |
56,682
-20,384
| -26% | -$809K |
|
430
TransDigm Group
TDG
$70.7B
| $2.02M | 0.02% |
2,257
-44,948
| -95% | -$35.5M |
|
|
NUVL
431
DELISTED
Nuvalent
NUVL
| $2.02M | 0.02% |
+47,850
| New | +$1.81M |
|
432
Vir Biotechnology
VIR
$1.56B
| $2M | 0.02% |
+81,386
| New | +$2.04M |
|
433
Fulcrum Therapeutics
FULC
$289M
| $1.97M | 0.02% |
+596,695
| New | +$1.75M |
|
434
MannKind Corp
MNKD
$1.2B
| $1.96M | 0.02% |
482,126
-1,352,154
| -74% | -$5.64M |
|
435
MacroGenics
MGNX
$247M
| $1.95M | 0.02% |
+364,700
| New | +$2.25M |
|
436
Progress Software
PRGS
$1.7B
| $1.93M | 0.02% |
+33,277
| New | +$1.89M |
|
437
ManpowerGroup
MAN
$2.5B
| $1.89M | 0.02% |
+23,785
| New | +$1.8M |
|
438
Celsius Holdings
CELH
$7.48B
| $1.88M | 0.02% |
37,875
-404,787
| -91% | -$16.1M |
|
439
Celldex Therapeutics
CLDX
$3.03B
| $1.85M | 0.02% |
54,499
-972
| -2% | -$32.8K |
|
440
Shutterstock
SSTK
$215M
| $1.83M | 0.02% |
37,558
+23,695
| +171% | +$1.35M |
|
|
TVRD
441
Tvardi Therapeutics
TVRD
$18.8M
| $1.79M | 0.02% |
17,538
+16,357
| +1,385% | +$2.25M |
|
|
MFM
442
Aberdeen Municipal Income Fund
MFM
$221M
| $1.78M | 0.02% |
348,464
-266,929
| -43% | -$1.37M |
|
443
Levi Strauss
LEVI
$9.53B
| $1.78M | 0.02% |
123,020
-261,069
| -68% | -$3.77M |
|
|
JSD
444
DELISTED
NUVEEN SHORT DURATION CREDIT OPPORTUNITIES FUND
JSD
| $1.77M | 0.02% |
153,500
-25,682
| -14% | -$297K |
|
445
Krispy Kreme
DNUT
$531M
| $1.75M | 0.02% |
118,645
-183,827
| -61% | -$2.75M |
|
446
Nuveen Preferred & Income Opportunities Fund
JPC
$2.91B
| $1.73M | 0.02% |
267,151
+34,501
| +15% | +$219K |
|
|
INFA
447
DELISTED
Informatica
INFA
| $1.72M | 0.02% |
92,767
+75,586
| +440% | +$1.25M |
|
448
Ziff Davis
ZD
$2.02B
| $1.72M | 0.02% |
+24,480
| New | +$1.68M |
|
|
ETO
449
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
ETO
$517M
| $1.71M | 0.02% |
74,467
| – | – |
|
|
NEWR
450
DELISTED
New Relic, Inc.
NEWR
| $1.69M | 0.02% |
25,797
+17,307
| +204% | +$1.25M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q2 2023 Portfolio in Review
As of Q2 2023, Woodline Partners held 838 positions worth $8.44B, up 15% from $7.35B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners deployed $577M of net new capital in Q2 2023, opening 218 new positions and adding to 181 existing holdings. Its largest new stake was Hess: 837,083 shares worth $114M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Keysight, an estimated $101M trimmed.
- Woodline Partners's largest Q2 2023 buy was Hess: 837,083 shares worth $114M.
- Woodline Partners added most to Johnson & Johnson in Q2 2023, an estimated $123M increase.
- Woodline Partners's biggest Q2 2023 reduction was Keysight, cutting an estimated $101M.
- Woodline Partners fully exited Baxter International in Q2 2023, selling an estimated $108M.
- Woodline Partners's ten largest holdings make up 16% of its $8.44B portfolio in Q2 2023.
- Woodline Partners opened 218 new positions and closed 220 in Q2 2023.
- Woodline Partners's portfolio value rose 15% quarter-over-quarter to $8.44B.
Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.